OTCMKTS:TCNNFTrulieve Cannabis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Trulieve Cannabis Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $12.72 -0.03 (-0.24 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$12.53Now: $12.72▼$12.9850-Day Range$12.23MA: $12.68▼$13.2352-Week Range$5.74Now: $12.72▼$14.72Volume108,300 shsAverage Volume231,617 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInstitutional OwnershipHeadlinesSocial Media Trulieve Cannabis Corp. operates as a medical marijuana company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients via home delivery. It produces approximately 150 stock keeping units, including nasal sprays, capsules, concentrates, syringes, cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridge. As of January 14, 2019, the company operated 24 dispensaries. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingTrulieve Cannabis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.04, Trulieve Cannabis has a potential upside of 104.7% from its current price of $12.72.Amount of Analyst CoverageTrulieve Cannabis has only been the subject of 3 research reports in the past 90 days. Previous Next 3.5 Community Rank Outperform VotesTrulieve Cannabis has received 60 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTrulieve Cannabis has received 26 “underperform” votes. (Add your “underperform” vote.)Community SentimentTrulieve Cannabis has received 69.77% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Trulieve Cannabis and other stocks. Vote “Outperform” if you believe TCNNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TCNNF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTrulieve Cannabis does not currently pay a dividend.Dividend GrowthTrulieve Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trulieve Cannabis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.40 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TCNNF Previous Symbol CUSIPN/A CIKN/A Webwww.trulieve.com Phone850-480-7955Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,000 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:TCNNF Rates by TradingView Receive TCNNF News and Ratings via Email Sign-up to receive the latest news and ratings for TCNNF and its competitors with MarketBeat's FREE daily newsletter. Trulieve Cannabis (OTCMKTS:TCNNF) Frequently Asked Questions How has Trulieve Cannabis' stock been impacted by COVID-19 (Coronavirus)? Trulieve Cannabis' stock was trading at $7.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TCNNF shares have increased by 65.2% and is now trading at $12.72. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Trulieve Cannabis? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Trulieve Cannabis. What price target have analysts set for TCNNF? 5 brokerages have issued 1 year target prices for Trulieve Cannabis' stock. Their forecasts range from $17.00 to $52.00. On average, they expect Trulieve Cannabis' share price to reach $26.04 in the next year. This suggests a possible upside of 104.7% from the stock's current price. View analysts' price targets for Trulieve Cannabis. Has Trulieve Cannabis been receiving favorable news coverage? Media headlines about TCNNF stock have been trending negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Trulieve Cannabis earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news about Trulieve Cannabis. Who are some of Trulieve Cannabis' key competitors? Some companies that are related to Trulieve Cannabis include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. Who are Trulieve Cannabis' key executives? Trulieve Cannabis' management team includes the following people: Ms. Kimberly Rivers, CEO & Chairman (Age 41)Mr. Mohan Srinivasan, Chief Financial Officer (Age 66)Mr. Jason Barry Pernell, Chief Information Officer (Age 41)Ms. Victoria Walker, Marketing Mang. (Age 34)Mr. Steven Ferrell, Sr. HR Director (Age 49) What is Trulieve Cannabis' stock symbol? Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF." How do I buy shares of Trulieve Cannabis? Shares of TCNNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Trulieve Cannabis' stock price today? One share of TCNNF stock can currently be purchased for approximately $12.72. What is Trulieve Cannabis' official website? The official website for Trulieve Cannabis is www.trulieve.com. How can I contact Trulieve Cannabis? The company can be reached via phone at 850-480-7955. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
